← Open Payments lookup

ANN MATAKAS: Open Payments

NPI 1265793319 · ROSWELL, NM. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$634 in 37 payments from 10 companies in 2025. Trend: 2023 $547 · 2024 $934 · 2025 $634

Food & beverage: $634
CompanyPaymentsAmount
ABBVIE INC.18$222
AstraZeneca Pharmaceuticals LP7$169
Xeris Pharmaceuticals, Inc.3$63
Otsuka America Pharmaceutical, Inc.2$40
Novo Nordisk Inc2$38
Boehringer Ingelheim Pharmaceuticals, Inc.1$24
Dexcom, Inc.1$23
Neurocrine BioSciences, Inc.1$20
Salix Pharmaceuticals, a division of Bausch Health US, LLC1$18
GlaxoSmithKline, LLC.1$17

Products named: QULIPTA, AIRSUPRA, BREZTRI, GVOKE HYPOPEN, UBRELVY, REXULTI, VRAYLAR, Wegovy.

Industry payments across NM — which companies pay providers there.